טוען...
5-ASA-loaded SiO(2) nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice
The targeting of 5-aminosalicylic acid (5-ASA), a first-line therapeutic agent for mild to moderate active ulcerative colitis (UC), to the site of inflammation has remained a challenge and an unmet requirement in the treatment of UC. However, nanoscale carriers for targeted drug delivery are promisi...
שמור ב:
| הוצא לאור ב: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367343/ https://ncbi.nlm.nih.gov/pubmed/28138699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6153 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|